[What is an efficient health intervention in Spain in 2020?]

Gac Sanit. 2020 Mar-Apr;34(2):189-193. doi: 10.1016/j.gaceta.2019.06.007. Epub 2019 Sep 24.
[Article in Spanish]

Abstract

Fifteen years ago, Gaceta Sanitaria published the article entitled "What is an efficient health technology in Spain?" The growing interest in setting the price of new technologies based on the value they provide to health systems and the experience accumulated by the countries in our environment make it opportune to review what constitutes an efficient health intervention in Spain in 2020. Cost-effectiveness analysis continues to be the reference method to maximize social health outcomes with the available resources. The interpretation of its results requires establishing reference values that serve as a guide on what constitutes a reasonable value for the health care system. Efficiency thresholds must be flexible and dynamic, and they need to be updated periodically. Its application should be based on and transparency, and consider other factors that reflect social preferences. Although setting thresholds is down to political decision-makers, in Spain it could be reasonable to use thresholds of 25,000 and 60,000 Euros per QALY. However, currently, in addition to determining exact figures for the threshold, the key question is whether the Spanish National Health System is able and willing to implement a payment model based on value, towards achieving gradual financing decisions and, above all, to improve the predictability, consistency and transparency of the process.

Keywords: Cost-effectiveness; Coste-efectividad; Economic evaluation; Efficiency; Eficiencia; Evaluación económica; Financiación; Financing; Health technology; Medicamento; Pharmaceuticals; Precio; Price; Tecnología sanitaria; Threshold; Umbral.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Australia
  • Biomedical Technology / economics*
  • Canada
  • Cost-Benefit Analysis*
  • Drug Costs
  • Efficiency
  • Health Care Costs
  • Health Resources / economics*
  • Health Resources / organization & administration
  • Humans
  • National Health Programs / economics*
  • National Health Programs / organization & administration
  • Netherlands
  • Quality-Adjusted Life Years*
  • Reference Values
  • Reimbursement, Incentive / economics
  • Spain
  • Sweden
  • United States